贝康医疗-B_Providing professional financial news and data related to 贝康医疗-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea

Scan QR Code

Download App